Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Br J Dermatol ; 169(6): 1223-32, 2013 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-23855377

RESUMO

BACKGROUND: Acute generalized exanthematous pustulosis (AGEP) is a severe cutaneous adverse reaction characterized by rash with sterile pustules, high fever and elevated circulating neutrophil counts. OBJECTIVES: To investigate the frequency and clinical features of AGEP systemic involvement. METHODS: This retrospective study included all patients hospitalized in our department between 2000 and 2010 with a discharge diagnosis of AGEP. Patients had to fulfil the following criteria: (i) a specific EuroSCAR score > 4 and (ii) biological and radiological work-up available. RESULTS: Among the 58 patients enrolled, 10 had at least one systemic involvement: hepatic function test results were abnormal for seven; six had renal insufficiency; two developed acute respiratory distress, with one patient's bronchoalveolar lavage fluid containing many neutrophils but no microorganisms; one was agranulocytotic. Mean peripheral neutrophil counts and mean C-reactive protein levels were elevated significantly in patients with systemic involvement. Amoxicillin rechallenge and hospitalization duration were associated with systemic involvement. AGEP systemic involvement was observed in 17% of cases studied, including liver, kidney, bone-marrow and lung involvement. Outcomes were favourable after drug withdrawal, and symptomatic and topical steroid treatments. CONCLUSIONS: The neutrophil count-systemic involvement association may suggest a role for neutrophils in AGEP systemic involvement. Physicians should be aware of the possibility of systemic involvement in AGEP and should actively look for signs of extracutaneous reactions.


Assuntos
Pustulose Exantematosa Aguda Generalizada/complicações , Pustulose Exantematosa Aguda Generalizada/patologia , Adulto , Idoso , Idoso de 80 Anos ou mais , Líquido da Lavagem Broncoalveolar/citologia , Humanos , Contagem de Leucócitos , Hepatopatias/complicações , Hepatopatias/patologia , Masculino , Pessoa de Meia-Idade , Neutrófilos/patologia , Insuficiência Renal/complicações , Insuficiência Renal/patologia , Síndrome do Desconforto Respiratório/complicações , Síndrome do Desconforto Respiratório/patologia , Estudos Retrospectivos , Adulto Jovem
2.
J Eur Acad Dermatol Venereol ; 27(7): 916-8, 2013 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-22239703

RESUMO

BACKGROUND AND OBJECTIVE: Studies of dermatological emergencies (DE) are few. We evaluated the activity in our DE unit in a 1-month retrospective study and compared the results with a similar study performed in the same department in 2000. METHODS: We reviewed the charts of all outpatients seen in the DE unit in January 2010, collecting data on age, sex, place of residence, referral mode, day and hour of consultation, true emergency or non-emergency, diagnosis and follow-up. RESULTS: In January 2010, we serviced 605 patients (58% males, mean age 40 ± 21 years), 21% more than in 2000; 43.5% were seen during off-duty hours vs. 49% in 2000 (P = 0.066), 49% were considered true emergencies vs. 43% in 2000 (P = 0.046), and 14% were referred by a physician vs. 23% in 2000 (P = 0.0001). In total, 35.2% of cases were infectious dermatoses in 2010 vs. 29% in 2000 (P = 0.026). Other diagnoses were eczema, urticaria and drug-related eruptions. Follow-up was suggested to 53.3% of the patients. CONCLUSIONS: Our DE unit satisfies a genuine need. Its activity increased over 10 years, most likely because of the decrease in the number of dermatologists in France. Although our results are close to those reported in the literature, comparison with previously published studies is difficult because of the heterogeneity of the definition of DE.


Assuntos
Dermatopatias/epidemiologia , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Criança , Pré-Escolar , Estudos Transversais , Emergências , Feminino , Humanos , Lactente , Masculino , Pessoa de Meia-Idade , Estudos Retrospectivos , Fatores de Tempo , Adulto Jovem
3.
J Eur Acad Dermatol Venereol ; 27(3): e424-7, 2013 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-23078647

RESUMO

BACKGROUND: High sun exposure during childhood is an important risk factor for skin cancers at adulthood. Paediatricians are first in line to provide sun protection (SP) information. OBJECTIVE: To describe paediatricians' attitudes towards SP counselling and compare French and American paediatricians' behaviours. METHODS: Methodology used by the American Academy of Pediatrics in 2001. Validation of the French version of the questionnaire. Survey of all 1108 paediatrician members of the Association Française de Pédiatrie Ambulatoire (AFPA) RESULTS More than 90% of paediatricians agreed that skin cancers are a Public Health concern, that preventing episodic high sun exposures during childhood would reduce the risk of adult melanoma, and that it is a paediatrician's role to educate parents/patients on SP. Three quarters reported counselling all of their patients. The most important SP recommendation was to avoid sun during peak hours, followed by sunscreen use. Only 48.3% of paediatricians rated SP as very important to their patients' health, at the 8th rank among selected preventive care topics. The most frequently identified barrier to SP counselling was cost of sunscreens followed by lack of sufficient time. CONCLUSIONS: The majority of paediatricians believe that prevention of skin cancers is a worthy issue and it is their role to educate patients, but less than half of them consider SP as an important topic among selected preventive care issues. Although paediatricians seem to know SP measures well, their (counselling?) seems to respond to patients' preoccupations more than to expert recommendations. French and American behaviours show some major differences.


Assuntos
Aconselhamento , Pediatria , Padrões de Prática Médica , Roupa de Proteção , Luz Solar/efeitos adversos , Protetores Solares/administração & dosagem , França , Humanos , Avaliação das Necessidades , Recursos Humanos
4.
Clin Microbiol Infect ; 18(4): 338-44, 2012 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-22429458

RESUMO

Insecticide treatment resistance is considered to be a major factor in the increasing number of infestations by head lice. The large insecticide selection pressure induced by conventional topical pediculicides has led to the emergence and spread of resistance in many parts of the world. Possible mechanisms of resistance include accelerated detoxification of insecticides by enzyme-mediated reduction, esterification, oxidation that may be overcome by synergistic agents such as piperonyl butoxide, alteration of the binding site, e.g. altered acetylcholinesterase or altered nerve voltage-gated sodium channel, and knockdown resistance (kdr). Clinical, parasitological and molecular data on resistance to conventional topical pediculicides show that treatments with neurotoxic insecticides have suffered considerable loss of activity worldwide. In particular, resistance to synthetic pyrethroids has become prominent, probably because of their extensive use. As other treatment options, including non-insecticidal pediculicides such as dimeticone, are now available, the use of older insecticides, such as lindane and carbaryl, should be minimized, owing to their loss of efficacy and safety concerns. The organophosphorus insecticide malathion remains effective, except in the UK, mostly in formulations that include terpineol.


Assuntos
Resistência a Inseticidas , Inseticidas/farmacologia , Infestações por Piolhos/parasitologia , Pediculus/efeitos dos fármacos , Acetilcolinesterase/química , Animais , Carbaril/efeitos adversos , Carbaril/farmacologia , Química Farmacêutica , Genes de Insetos , Preparações para Cabelo/efeitos adversos , Preparações para Cabelo/farmacologia , Hexaclorocicloexano/efeitos adversos , Hexaclorocicloexano/farmacologia , Humanos , Inseticidas/efeitos adversos , Infestações por Piolhos/tratamento farmacológico , Infestações por Piolhos/patologia , Malation/efeitos adversos , Malation/farmacologia , Pediculus/enzimologia , Pediculus/genética , Permetrina/efeitos adversos , Permetrina/farmacologia , Medicamentos sob Prescrição/efeitos adversos , Medicamentos sob Prescrição/farmacologia
5.
Ann Dermatol Venereol ; 138(2): 135-9, 2011 Feb.
Artigo em Francês | MEDLINE | ID: mdl-21333826

RESUMO

BACKGROUND: Tyrosine kinase inhibitors are now established as valuable therapy in chronic myelogenous leukaemia (CML). They induce several types of cutaneous side effect, the most common being non-specific maculopapular rash and periocular oedema. Rare cases of panniculitis have been described in patients with CML treated with imatinib mesilate and dasatinib. We report a case of recurrent panniculitis in a patient with CML treated successively with imatinib mesilate and dasatinib. CASE REPORT: An 81-year-old woman diagnosed with chronic CML experienced two episodes of neutrophilic panniculitis following imatinib mesilate therapy, as well as relapse following replacement of imatinib mesilate by dasatinib. Several skin biopsies showed a neutrophilic infiltrate throughout the fatty tissue lobules, without vasculitis and without any evidence of bacterial infection. The symptoms gradually subsided without discontinuation of tyrosine kinase inhibitor therapy. DISCUSSION: Neutrophilic panniculitis is uncommon among patients treated with tyrosine kinase inhibitors and has only been described in patients treated for chronic myeloid leukaemia. We discuss the potential causative role of imatinib mesilate and dasatinib in onset of the disease, as well as differential diagnosis of neutrophilic panniculitis, which resembles subcutaneous Sweet's syndrome.


Assuntos
Protocolos de Quimioterapia Combinada Antineoplásica/toxicidade , Toxidermias/diagnóstico , Leucemia Mielogênica Crônica BCR-ABL Positiva/tratamento farmacológico , Neutrófilos/efeitos dos fármacos , Paniculite/induzido quimicamente , Piperazinas/toxicidade , Inibidores de Proteínas Quinases/toxicidade , Pirimidinas/toxicidade , Tiazóis/toxicidade , Idoso de 80 Anos ou mais , Protocolos de Quimioterapia Combinada Antineoplásica/uso terapêutico , Benzamidas , Biópsia , Dasatinibe , Toxidermias/patologia , Feminino , Humanos , Mesilato de Imatinib , Neutrófilos/patologia , Paniculite/diagnóstico , Paniculite/patologia , Piperazinas/administração & dosagem , Inibidores de Proteínas Quinases/administração & dosagem , Pirimidinas/administração & dosagem , Recidiva , Pele/efeitos dos fármacos , Pele/patologia , Tiazóis/administração & dosagem
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...